Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group (Q37212223)
Jump to navigation
Jump to search
scientific article published on 30 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group |
scientific article published on 30 March 2009 |
Statements
1 reference
Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group (English)
1 reference
David S Miller
1 reference
John A Blessing
1 reference
Carolyn N Krasner
1 reference
Robert S Mannel
1 reference
Parviz Hanjani
1 reference
Michael L Pearl
1 reference
Steven E Waggoner
1 reference
Cecelia H Boardman
1 reference
30 March 2009
1 reference
1 reference
2686-2691
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference